Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer

Go back to Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
(NASDAQ: NTLA) Delayed: 11.21 +0.05 (0.45%)
Previous Close $11.16    52 Week High $30.40 
Open $11.00    52 Week Low $11.86 
Day High $11.24    P/E N/A 
Day Low $10.58    EPS $0.00 
Volume 3,564,678